Onset of Clinical Response with Deucravacitinib in Patients with Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b/4 PSORIATYK SCALP Trial. J of Skin. 2025;9(2):s539. doi:10.25251/skin.10.supp.539